Shattuck Labs (STTK) Change in Account Payables (2019 - 2026)
Shattuck Labs' (STTK) quarterly Change in Account Payables came in at -$911000.0 in Q1 2026, down 2.82% year-on-year from -$937451.8 in Q1 2025, and down 197.02% on a QoQ basis from $939000.0 in Q4 2025.
Shattuck Labs (STTK) Change in Account Payables (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Change in Account Payables data on file, last reported at -$911000.0 in Q1 2026.
- On a quarterly basis, Change in Account Payables fell 2.82% year-over-year to -$911000.0 in Q1 2026; TTM through Mar 2026 was -$343000.0, a 64.27% increase from a year earlier, with the FY2025 full-year figure at -$318000.0, down 138.22% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$911000.0, down from $939000.0 in the prior quarter.
- Over the last five years, Change in Account Payables for STTK reached as high as $4.4 million in Q4 2022 and fell as low as -$7.7 million in Q1 2022.
- Historically, Change in Account Payables has averaged -$521647.1 across 5 years, with a median of -$475000.0 in 2023.
- Across the five-year window, Change in Account Payables plunged 723.53% in 2022 and soared 497.39% in 2025, its largest moves.
- Year by year, Change in Account Payables stood at $4.4 million in 2022, then plunged by 110.91% to -$475000.0 in 2023, then slipped by 6.95% to -$508000.0 in 2024, then jumped by 284.84% to $939000.0 in 2025, then plunged by 197.02% to -$911000.0 in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were -$911000.0 in Q1 2026, $939000.0 in Q4 2025, and $687000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Shattuck Labs | 795.74 Mn | 795.74 Mn | - | -911,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -911,000.00 |
| Mar 31, 2026 | -911,000.00 |
| Dec 31, 2025 | 939,000.00 |
| Dec 31, 2025 | 939,000.00 |
| Sep 30, 2025 | 687,000.00 |
| Sep 30, 2025 | 687,000.00 |
| Jun 30, 2025 | -1.06 Mn |
| Jun 30, 2025 | -1.06 Mn |
| Mar 31, 2025 | -886,000.00 |
| Mar 31, 2025 | -886,000.00 |
| Dec 31, 2024 | -508,000.00 |
| Dec 31, 2024 | -508,000.00 |
| Sep 30, 2024 | 115,000.00 |
| Sep 30, 2024 | 115,000.00 |
| Jun 30, 2024 | 319,000.00 |
| Jun 30, 2024 | 319,000.00 |
| Mar 31, 2024 | 906,000.00 |
| Mar 31, 2024 | 906,000.00 |
| Dec 31, 2023 | -475,000.00 |
| Dec 31, 2023 | -475,000.00 |